Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abbott Labs (ABT – Research Report), Sanofi (SNYNF – Research Report) and Siemens Healthineers AG (SEMHF – Research Report).
Abbott Labs (ABT)
TD Cowen analyst Josh Jennings maintained a Buy rating on Abbott Labs today and set a price target of $130.00. The company’s shares closed last Thursday at $114.49, close to its 52-week high of $115.83.
According to TipRanks.com, Jennings is a 4-star analyst with an average return of
Abbott Labs has an analyst consensus of Strong Buy, with a price target consensus of $126.15, which is an 11.9% upside from current levels. In a report issued on January 22, UBS also maintained a Buy rating on the stock with a $136.00 price target.
See the top stocks recommended by analysts >>
Sanofi (SNYNF)
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Sanofi, with a price target of EUR80.00. The company’s shares closed last Thursday at $96.59.
According to TipRanks.com, Papadakis is a 4-star analyst with an average return of
Currently, the analyst consensus on Sanofi is a Moderate Buy with an average price target of $99.34.
Siemens Healthineers AG (SEMHF)
In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Siemens Healthineers AG, with a price target of EUR60.00. The company’s shares closed last Thursday at $58.20.
According to TipRanks.com, Friedrichs is a 1-star analyst with an average return of
Siemens Healthineers AG has an analyst consensus of Strong Buy, with a price target consensus of $64.45, which is a 10.7% upside from current levels. In a report issued on January 18, Berenberg Bank also maintained a Buy rating on the stock with a EUR58.20 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABT:
